Evidence map›Paper›PMID 27209022›Full record

ArticleJournal of neuroinflammation2016

Complement system activation contributes to the ependymal damage induced by microbial neuraminidase.

Pablo Granados-Durán, María Dolores López-Ávalos, Timothy R Hughes, Krista Johnson, B Paul Morgan, Paul P Tamburini, Pedro Fernández-Llebrez, Jesús M Grondona

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Control of Innate Immunity by Sialic Acids in the Nervous Tissue.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Pablo Granados-DuránDepartamento de Biología Celular, Genética y Fisiología, IBIMA, Facultad de Ciencias, Universidad de Málaga, Málaga, 29071, Spain.
María Dolores López-ÁvalosDepartamento de Biología Celular, Genética y Fisiología, IBIMA, Facultad de Ciencias, Universidad de Málaga, Málaga, 29071, Spain.
Timothy R HughesInstitute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
Krista JohnsonAlexion Pharmaceuticals Inc., 352 Knotter Drive, Cheshire, CT, 06410, USA.
B Paul MorganInstitute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
Paul P TamburiniAlexion Pharmaceuticals Inc., 352 Knotter Drive, Cheshire, CT, 06410, USA.
Pedro Fernández-LlebrezDepartamento de Biología Celular, Genética y Fisiología, IBIMA, Facultad de Ciencias, Universidad de Málaga, Málaga, 29071, Spain.
Jesús M GrondonaDepartamento de Biología Celular, Genética y Fisiología, IBIMA, Facultad de Ciencias, Universidad de Málaga, Málaga, 29071, Spain. grondona@uma.es.
Alexion Pharmaceuticals (United States) · USCardiff University · GBInstituto de Investigación Biomédica de Málaga · ESUniversidad de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the rat brain, a single intracerebroventricular injection of neuraminidase from Clostridium perfringens induces ependymal detachment and death. This injury occurs before the infiltration of inflammatory blood cells; some reports implicate the complement system as a cause of these injuries. Here, we set out to test the role of complement.

methodsThe assembly of the complement membrane attack complex on the ependymal epithelium of rats injected with neuraminidase was analyzed by immunohistochemistry. Complement activation, triggered by neuraminidase, and the participation of different activation pathways were analyzed by Western blot. In vitro studies used primary cultures of ependymal cells and explants of the septal ventricular wall. In these models, ependymal cells were exposed to neuraminidase in the presence or absence of complement, and their viability was assessed by observing beating of cilia or by trypan blue staining. The role of complement in ependymal damage induced by neuraminidase was analyzed in vivo in two rat models of complement blockade: systemic inhibition of C5 by using a function blocking antibody and testing in C6-deficient rats.

resultsThe complement membrane attack complex immunolocalized on the ependymal surface in rats injected intracerebroventricularly with neuraminidase. C3 activation fragments were found in serum and cerebrospinal fluid of rats treated with neuraminidase, suggesting that neuraminidase itself activates complement. In ventricular wall explants and isolated ependymal cells, treatment with neuraminidase alone induced ependymal cell death; however, the addition of complement caused increased cell death and disorganization of the ependymal epithelium. In rats treated with anti-C5 and in C6-deficient rats, intracerebroventricular injection of neuraminidase provoked reduced ependymal alterations compared to non-treated or control rats. Immunohistochemistry confirmed the absence of membrane attack complex on the ependymal surfaces of neuraminidase-exposed rats treated with anti-C5 or deficient in C6.

conclusionsThese results demonstrate that the complement system contributes to ependymal damage and death caused by neuraminidase. However, neuraminidase alone can induce moderate ependymal damage without the aid of complement.

Indexed as

AnimalsAntibodiesCells, CulturedCerebral VentriculitisComplement C3Complement C5Complement C6Complement Membrane Attack ComplexDisease Models, AnimalEpendymaGene Expression RegulationInjections, IntraventricularLectinsMaleNeuraminidaseRatsAntibodiesComplement C3Complement C5Complement C6Complement Membrane Attack ComplexLectinsNeuraminidaseVimentinAnti-C5Brain ventriclesC6-deficient ratsComplement systemEpendymal cellsInflammationNeuraminidase

Identifiers

PMID27209022
PMCPMC4875702
OpenAlexW2401873130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.